|
 |
|
| |
|
Newsletter Sponsor
|
|
Transforming CDMO Partnerships through a Holistic Understanding of Quality
In pharmaceutical manufacturing, a commitment to quality is fundamental to accelerating time to market, minimizing risk, increasing ROI, and developing life-saving medicines.
However, quality is often mischaracterized by assigning responsibility to a single team, describing it as an end-of-the-line activity, or conflating it with compliance.
While each of these factors is relevant, none defines it. Our whitepaper analyzes the key indicators of a CDMO quality mindset that permeates every aspect of drug development.
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Events
|
|
|
| |
|
|
|
Pharmacovigilance World 2023
London, United Kingdom – 11/01/2023
The Pharmacovigilance World 2023 will provide a platform for the participants to discuss, share and stay updated with present state of affairs in ...
event details » |
 |
|
|
|
|
 |
|
|
